1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Small Business Innovation Research (SBIR) Program – CDC is sponsored by Centers for Disease Control and Prevention (CDC). The CDC SBIR program provides funding opportunities for small businesses to develop innovative solutions to public health challenges, including health information technology. This can encompass AI applications that align with CDC's mission.
Get alerted about grants like this
Save a search for “Centers for Disease Control and Prevention (CDC)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Small Business Innovation Research Funding | Extramural Research | CDC Skip directly to site content Small Business Innovation Research Funding NIOSH co-sponsors grants for the Small Business Innovation Research (SBIR) program. SBIR helps businesses commercialize innovations from federal research. Interested applicants are encouraged to review the list of NIOSH topics.
The HHS Small Business Innovation Research (SBIR) program is a partnership among federal agencies. The Centers for Disease Control and Prevention, the Food and Drug Administration, and the National Institutes of Health participate.
The goals of the program are to: Stimulate technological innovation Meet federal research and development needs Increase private sector commercialization of innovations developed through federal R&D funding Foster and encourage participation in innovation and entrepreneurship. NIOSH participates by funding SBIR grants related to occupational safety and health. SBIR is a phased program.
The main objective Phase I is to establish the technical merit and feasibility of the proposed research and development efforts. Phase II continues the R&D efforts to advance the technology toward ultimate commercialization. At the end of Phase II, small businesses are expected to fully commercialize their product or technology using non-SBIR funds.
These funds could be either federal or non-federal. Interested applicants are encouraged to review the NIOSH topics identified in SBIR/STTR Program Descriptions and Research Topics Document (pgs 180-184) These funding announcements have expired and been reissued. The links are included here as a reference.
R43/R44 Small Business Innovation Research (SBIR) Grant - Phase I and Fast-Track R43/R44 Small Business Innovation Research (SBIR) Grant - Phase I and Fast-Track R43/R44 Small Business Innovation Research (SBIR) Grant - Phase I, Phase II, and Fast-Track R43/R44 Small Business Innovation Research (SBIR) Grant - Phase I, Phase II, and Fast-Track National Institute for Occupational Safety and Health The Occupational Safety and Health Act of 1970 established NIOSH as a research agency focused on the study of worker safety and health, and empowering employers and workers to create safe and healthy workplaces.
Applying for Extramural Funding Research and Training Highlights
According to the current listing, eligibility includes: U. S. -based small businesses with fewer than 500 employees. Confirm the full requirements in the official notice before applying.
The current listing shows phase I: up to $323,090 for 6 months to 2 years; Phase II: up to $2,153,927 for up to 2 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Small Business Innovation Research (SBIR) Program – CDC is funded by Centers for Disease Control and Prevention (CDC). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Comprehensive Addiction and Recovery Act (CARA) Community-based Coalition Enhancement Grants to Address Local Drug Crises is sponsored by Centers for Disease Control and Prevention (CDC) / Office of National Drug Control Policy (ONDCP). Enhancement grants for current or formerly funded Drug-Free Communities (DFC) Support Program recipients to prevent and reduce the use of opioids and methamphetamines and the misuse of prescription drugs among youth ages 12-18.
Comprehensive Addiction and Recovery Act (CARA) Community-based Coalition Enhancement Grants to Address Local Drug Crises Grants (CARA Local Drug Crises Grants) is sponsored by Centers for Disease Control and Prevention (CDC), National Center for Injury Prevention and Control (NCIPC). This program aims to prevent and reduce the use of opioids and methamphetamines and the misuse of prescription drugs among youth ages 12-18 in communities throughout the United States.
HRSA's brand-new Rural Hospital Provider Assistance Program splits $24.75M among eligible rural hospitals with 50 or fewer beds and a Medicare wage index under 0.90. It's not scored competitively — every eligible hospital that applies by July 27 gets a roughly equal share. Here's how the three eligibility numbers work and why registration, not narrative, is the real risk.
Read articleHUD announced the FY25 Rural Capacity Building NOFO on May 18, 2026 with a July 6 deadline. Section 4 has three statutory intermediaries — Enterprise, LISC, and Habitat. RCB is a different door, and most rural housing nonprofits are misreading which one they qualify for.
Read articleThe CDC's Notice of Funding Opportunity CDC-RFA-JG-26-0056, Continuing to Enhance Global Health Security, closes for applications on June 25, 2026, with $75 million on the table and eight cooperative agreements anticipated. The NOFO sits inside an unusually compressed window for global health implementing partners — after the USAID dismantling and the 2025 CDC reorganization, this is one of the largest remaining flexible federal vehicles for outbreak-prevention work executed through bilateral partnerships with foreign health ministries. Here is what the solicitation requires, why the eligibility design favors specific applicant types, and what to do if you are still considering whether to apply.
Read article